FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: Anaren

Sort
E.g., 2013-05-22
E.g., 2013-05-22
Enter a comma separated list of user names.

3SBio Inc. (Nasdaq:SSR) announced that it has received official notification from China's State Food and Drug Administration ("SFDA") granting 3SBio manufacturing approval for a TPIAO label extension for the treatment of idiopathic thrombocytopenic purpura ("ITP"). The approval application was submitted in December 2008.

Power3 Medical Products, Inc. (PWRM.OB) is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).

ADVERTISE WITH US